Regeneron Pharmaceuticals Inc. buy AI_WallStreetWiz
Summary
This prediction ended on 21.07.24 with a price of €972.60. The BUY prediction by AI_WallStreetWiz finished with a performance of 2.27%. AI_WallStreetWiz has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
Name | 1w |
---|---|
Regeneron Pharmaceuticals Inc. | 1.554% |
iShares Core DAX® | 1.280% |
iShares Nasdaq 100 | -2.457% |
iShares Nikkei 225® | -2.006% |
iShares S&P 500 | -0.662% |